Selected article for: "basic reproductive number and human human transmission"

Author: Eifan, Saleh A.; Nour, Islam; Hanif, Atif; Zamzam, Abdelrahman M.M.; AlJohani, Sameera Mohammed
Title: A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia
  • Document date: 2017_6_6
  • ID: sk2n2gxw_27
    Snippet: The present study reported the highest R values (Table 2 ) ever observed for MERS-CoV, however other studies reported R of up to 0.73 (Kucharski and Edmunds, 2015) , 0.69 (Breban et al., 2013; Poletto et al., 2014) and 0.63 (Cauchemez et al., 2014) . The probable reasons for the surge of R value in the current study could be the absence of a vaccine or a treatment, besides the inefficient control measures in health care centers and hospitals as m.....
    Document: The present study reported the highest R values (Table 2 ) ever observed for MERS-CoV, however other studies reported R of up to 0.73 (Kucharski and Edmunds, 2015) , 0.69 (Breban et al., 2013; Poletto et al., 2014) and 0.63 (Cauchemez et al., 2014) . The probable reasons for the surge of R value in the current study could be the absence of a vaccine or a treatment, besides the inefficient control measures in health care centers and hospitals as most of the observed cases were documented to be interand intra-hospital transmissions (Drosten et al., 2015; Oboho et al., 2015) . Furthermore, Cauchemez et al. (2014) mentioned that R 0 could range from 0.8 to 1.3 in the absence of the infection control measures. The results of current study are in agreement with the findings of Cauchemez et al. (2014) . A study in South Korea (Kucharski and Althaus, 2015) highlighted the risk of super-spreading events of MERS-CoV infection with relatively low basic reproductive number (R = 0.47) and should be considered as warning for future outbreak events in Saudi Arabia with the prediction of relatively higher R value. Therefore, future tracking of infections would add value to our understanding of viral transmissibility pattern as well as contracting the CIs around the R 0 value. Appropriate monitoring of cases as well as enhanced traceability procedures are important to reduce transmission rate, diminish any possible opportunity of viral adaptation to human-to-human transmission and to obtain reliable data for periodical update of the R value (Min et al., 2016) .

    Search related documents:
    Co phrase search for related documents
    • appropriate monitoring and current study: 1, 2, 3
    • appropriate monitoring and health care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • appropriate monitoring and human human: 1, 2
    • appropriate monitoring and human human transmission: 1
    • appropriate monitoring and infection control: 1, 2, 3, 4
    • appropriate monitoring and present study: 1
    • appropriate monitoring and transmission rate: 1
    • appropriate monitoring and treatment vaccine: 1
    • basic reproductive number and current study: 1, 2
    • basic reproductive number and health care: 1, 2, 3, 4
    • basic reproductive number and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • basic reproductive number and human human transmission: 1, 2, 3, 4, 5, 6, 7
    • basic reproductive number and infection control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • basic reproductive number and present study: 1, 2, 3, 4
    • basic reproductive number and reproductive number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87
    • basic reproductive number and super spread: 1, 2
    • basic reproductive number and super spread event: 1
    • basic reproductive number and transmission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • basic reproductive number and treatment vaccine: 1, 2